Treatment of HIV/AIDS at South Africa's Largest Employers: Myth and Reality


Administrators will be completing a maintenance upgrade between the hours of 5am and 7am EDT on July 28th. The system will remain in a read only state during the duration of this period. We apologize for any inconvenience and recommend returning to the service at a later time to submit content.

Show simple item record Connelly, Patrick Rosen, Sydney 2005-06-01 2010-01-28T19:32:21Z 2010-01-28T19:32:21Z 2010-01-28T19:32:21Z
dc.identifier.uri en_US
dc.description.abstract Background: In the past three years, many large employers in South Africa have announced publicly their intention of making antiretroviral treatment (ART) available to employees. Reports of the scope and success of these programs have been mostly anecdotal. This study surveyed the largest private sector employers in South Africa to determine the proportion of employees with access to ART through employer-sponsored HIV/AIDS treatment programs. Methods: All 64 private sector and parastatal employers in South Africa with more than 6,000 employees were identified and contacted. Those that agreed to participate were interviewed by telephone using a structured questionnaire. Results: 52 companies agreed to participate. Among these companies, 63% of employees had access to employer-sponsored care and treatment for HIV/AIDS. Access varied widely by sector, however. Approximately 27% of suspected HIV-positive employees were enrolled in HIV/AIDS disease management programs, or 4.4% of the workforce overall. Fewer than 4,000 employees in the entire sample were receiving antiretroviral therapy. In-house (employer) disease management programs and independent disease management programs achieved higher uptake of services than did medical aid schemes. Conclusions: Publicity by large employers about their treatment programs should be interpreted cautiously. While there is a high level of access to treatment, uptake of services is low and only a small fraction of employees medically eligible for antiretroviral therapy are receiving it. en_US
dc.relation.ispartofseries HDDP No 5.;Health & Development Paper Series
dc.subject HIV/AIDS en_US
dc.subject South Africa en_US
dc.subject Private sector en_US
dc.subject Antiretroviral therapy en_US
dc.subject Disease management program en_US
dc.title Treatment of HIV/AIDS at South Africa's Largest Employers: Myth and Reality en_US
dc.type Working Paper en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search OpenBU


Deposit Materials